BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  With Pivotal WHIM Readout Ahead, 2022 Could be Decisive Year for X4

  Boston-based X4 Pharmaceuticals reported its first-quarter financial report today. Of note was the company’s cash, cash equivalents & restricted cash, which was $67.7 million as of March 31, 2022.

  May 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Cullinan Oncology and Taiho Reunite to Co-Develop NSCLC Drug

  Cullinan and Taiho announced that Taiho was acquiring Cullinan Pearl and will co-develop and co-commercialize their non-small cell lung cancer drug.

  May 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Industry Experts Predict Biologics CDMO Market Will Hit $31M By 2030

  A recent research report points to the CDMO market heating up. P&S projected the global biologics CDMO market would hit $31.839 million by 2030.

  May 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise

  CRISPR reported that the overall response rate (ORR) was 71% with 29% of patients experiencing a complete response. The data will be presented at EHA 2022.

  May 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  TCR² Looks Ahead to Key Year for Lead Therapeutic Candidate

  TCR² Therapeutics provided updates regarding the 2022 first quarter financial results and progress made towards regulatory approval for gavo-cel and TC-510.

  May 12, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Drug Development

  BMS & BridgeBio Team Up in Nearly $1B Oncology Pact

  BridgeBio announced it has signed an exclusive deal with Bristol-Myers Squibb to develop and commercialize a potential treatment for cancer.

  May 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Drug Development

  Stealth Clinches Orphan Drug Designation in DMD

  Stealth BioTherapeutics has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for elamipretide.

  May 12, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Research Roundup: Stressing Cells May Mitigate Dementia and Another Clue to Parkinson’s Disease

  Tangles of toxic proteins are associated with various dementias, such as Alzheimer’s disease. Often, these tangles are misfolded proteins. Now, researchers have identified a new mechanism that might reverse the build-up of these aggregates.

  May 12, 2022

   · 

  6 min read

   · 

  Mark Terry
• 

  Career Advice

  How to Negotiate Pay As a Remote Employee

  If you’re ready to start earning the salary you deserve, here are some tips to help you recognize your worth and negotiate pay as a remote employee.

  May 12, 2022

   · 

  4 min read

   · 

  Franklin Carpenter
• 

  Drug Development

  Scientists Rejuvenate Skin Cells by 30 Years, with Pioneering Potential

  A group of scientists from the Babraham Institute in the United Kingdom has successfully rejuvenated skin cells by 30 years, observing several benefits of the functionally younger cells.

  May 12, 2022

   · 

  4 min read

   · 

  Abbey Glasure